CompChem Solutions - Congratulations to Inaki Morao of Evotec, Oxford. And a huge thank you to Professor Bobby Glen of the Unilever Centre, Cambridge, for pulling the lucky winner's name from the
Life Sciences company Evotec expands at Milton Park - Advanced Oxford
EVOequity – Evotec ActionPlan 2025
Evotec forms Oxford initiative to spawn AI-enabled startups | Fierce Biotech
Evotec expands again at Milton Park - Advanced Oxford
Evotec expands again at Milton Park near Oxford - The Business Magazine
LAB282
Evotec Invests in Oxford University Spinout Cell Therapy Company OxVax
Evotec to undergo sustainable expansion at Milton Park
Evotec expands Oxfordshire site and pays tribute to British chemist & Nobel prize winner - The Business Magazine
John Barker | LinkedIn
KMS TEAM – Evotec
Simon Reeves - Information Technology System Engineer - Evotec | LinkedIn
LAB282 - Evotec
Oxford University, Sensyne Health, Evotec, and OSI create new partnership called LAB10x to accelerate data-driven drug discovery powered by AI - Oxford University Innovation
4.1.3 Evotec logo_LD with text - Oxford University Innovation
LAB282 – a Unique Partnership Supporting Innovation from Academic Research | Oxford
Evotec invests into Oxford Cell Therapy Company "OxVax" — OxVax Ltd
EVOTEC EXPANDS ITS PROPRIETARY PATIENT DATABASE INTO LIVER DISEASE WITH UNIQUE ACCESS TO QUOD BIOBANK
Evotec acquires Aptuit - BaseLaunch
Aptuit-sold-300-million
Former Evotec COO joins Orbit Discovery's Board of Directors - Oxford Investment Consultants
Evotec Sells its Chemical Development Business to Aptuit for GBP 31.5m (approx. EUR 46.4m; US$ 63.9m) in Cash
Oxford, Evotec Partner on Drug Discovery | Science and Enterprise
LAB282 – a Unique Partnership Supporting Innovation from Academic Research | Oxford
Evotec to fill pre-IND service gap with $300M Aptuit buy | Fierce Biotech